Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
ID: 343407Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering Bioengineering Research Grants (BRG) under the funding opportunity announcement PAR-22-242, aimed at fostering interdisciplinary collaborations between life and physical sciences to address critical biomedical challenges. The grants encourage innovative research that enhances understanding of health and disease, improves medical practices, and meets unmet clinical needs, with applications being accepted from a diverse range of eligible entities, including educational institutions and community organizations. This funding opportunity is crucial for driving technological advancements in biomedical research, with a funding period of up to five years, contingent upon NIH appropriations, and applications must be submitted by September 7, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is announcing the Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) under FOA number PAR-22-242. This funding opportunity aims to foster interdisciplinary collaborations between life sciences and physical sciences to develop innovative bioengineering solutions to critical biomedical problems. Projects should propose research that enhances understanding of health and disease, improves medical practices, and fulfills unmet clinical needs. Applications can be new or involve resubmissions and must align with the missions of participating NIH institutes, including NCI, NEI, NIAMS, NICHD, NIDCR, NIDCD, and NINDS. Applicants are encouraged to submit distinct applications for different scientific inquiries. The application process requires adherence to strict guidelines and registration through NIH’s submission platforms. Key eligibility criteria include various educational and governmental entities, with a focus on diverse participation in research. The overall goal is to drive technological advancements in biomedical research with a funding period of up to five years, contingent upon NIH appropriations. Successful applications will undergo peer review for scientific merit and must demonstrate innovative approaches that advance knowledge in the biomedical fields. Applicants are urged to finalize submissions by outlined deadlines to ensure adherence to compliance expectations and avoid delays in funding.
    Similar Opportunities
    Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Bioengineering Research Grants (BRG) to encourage multidisciplinary collaborations that address significant biomedical challenges through innovative technologies. This funding opportunity aims to integrate life and physical sciences to accelerate the adoption of promising tools and methods in clinical or translational science, with a focus on projects that may involve clinical trials assessing functionality or performance in real-world settings. Eligible applicants include a wide range of organizations such as higher education institutions, non-profits, and foreign entities, with no cost-sharing requirement, and applications are due by September 7, 2025. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-22-243.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Exploratory/Developmental Bioengineering Research Grants (EBRG) under the R21 mechanism, aimed at fostering innovative engineering solutions to advance biomedical research. This funding opportunity encourages applications from a diverse range of organizations, including higher education institutions and nonprofits, to support exploratory projects that demonstrate feasibility and potential utility in addressing critical challenges in biomedical research and clinical care delivery, without involving clinical trials. The initiative emphasizes collaboration between quantitative and physical scientists and biomedical researchers, aiming to facilitate early-stage developments that can lead to significant advancements in medical technologies and methods. The funding ceiling is set at $275,000 over two years, with applications due by January 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-090.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Exploratory/Developmental Bioengineering Research Grants (EBRG) under the R21 funding mechanism, aimed at fostering innovative projects that address significant biomedical challenges. This funding opportunity encourages applications that explore new capabilities or improvements in biomedical research, clinical care delivery, and accessibility, with a focus on groundbreaking engineering research and collaboration across diverse scientific disciplines. Eligible applicants include higher education institutions, nonprofits, and small businesses, with a budget cap of $275,000 over two years, and applications are due by January 7, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-22-091.html.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research between academic institutions and industrial partners to accelerate the development of innovative bioengineering tools addressing critical biomedical challenges. This initiative seeks multidisciplinary teams that integrate engineering principles to create robust solutions capable of enhancing life sciences understanding and medical practices within a 5-10 year timeframe. The program emphasizes the importance of partnerships in overcoming development barriers and facilitating technology validation and commercialization, ultimately aiming to improve patient health outcomes. Interested applicants can find more details and submit inquiries via the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with applications due by January 7, 2025.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)" aimed at enhancing biomedical engineering education through innovative team-based design courses. This initiative seeks to support educational programs that prepare undergraduate students in biomedical engineering/bioengineering fields to meet national biomedical needs, with a focus on promoting health equity and universal design. Institutions can apply for grants of up to $40,000 per year for projects lasting up to five years, with a submission deadline of January 30, 2025. Interested applicants should ensure compliance with eligibility criteria and submit detailed proposals that include innovative educational plans and collaborations with relevant disciplines; for further inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs)." This initiative aims to enhance research capacity, technology innovation, and educational opportunities in biomedical engineering and related fields at HBCUs through a two-phase funding approach, with Phase I (UG3) offering up to $300,000 annually for planning and Phase II (UH3) allowing for up to $1,000,000 per year for full-scale program implementation. The program emphasizes the importance of diversity in the scientific workforce and seeks to leverage HBCUs' talent to address health disparities in the U.S. Interested applicants must submit their proposals by September 30, 2025, and can find additional information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Collaborative Program Grant for Multidisciplinary Teams (RM1), aimed at funding integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to tackle complex biomedical questions. This initiative emphasizes the need for collaborative efforts that demonstrate synergy and diversity, with the goal of achieving significant scientific advancements within the mission of the National Institute of General Medical Sciences (NIGMS). Funding is available for new, renewal, and resubmission applications, with anticipated budgets ranging from $700,000 to $1.5 million per year, and applications must be submitted by January 27, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Bridges to the Doctorate Research Training Program (T32)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bridges to the Doctorate Research Training Program (T32), a federal grant aimed at enhancing participation in the biomedical research workforce by improving training for master's students and facilitating their transition to Ph.D. programs. This program seeks to support eligible domestic organizations in developing effective, evidence-informed approaches to biomedical graduate training and mentoring, with a strong emphasis on outreach to underrepresented groups to promote diversity within the research community. The initiative requires partnerships between at least two postsecondary educational organizations—one focused on master's training and the other on Ph.D. training—while providing comprehensive financial support for trainees, including stipends and travel expenses. Interested applicants must adhere to strict eligibility criteria, with a preference for institutions such as Historically Black Colleges and Universities (HBCUs) and Tribally Controlled Colleges and Universities (TCCUs). The application deadline is September 28, 2026, and further inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate Research Training Program (T34)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bridges to the Baccalaureate Research Training Program (T34) to enhance diversity within the biomedical research workforce by supporting structured training for students transitioning from associate degree-granting institutions to baccalaureate colleges. This program aims to foster partnerships between eligible institutions to implement evidence-informed training and mentoring, which includes didactic education, research experiences, and career development activities, specifically targeting underrepresented groups in STEM fields. Funding is available for up to five years, covering trainee stipends, tuition, and travel to scientific meetings, with applications due by September 25, 2024. Interested institutions can find more information and application details at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.